Discover 1,108 paid clinical trials in Hartford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,108
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
for
Renal Cell Carcinoma (RCC),
Location: New Haven CT, Boston MA, New York NY, Hackensack NJ,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT05176483
Phase1, Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: New Haven CT, Charlottesville VA, Cleveland OH,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase2, Recruiting
A Trial of Varenicline for E-cigarette Cessation
for
E-cigarette Use, Vaping, Nicotine Dependence
Location: New Haven CT, Charleston SC
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT07040566
Phase2, Recruiting
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
for
Advanced/Metastatic Solid Tumors, Bladder Cancer,
Location: New Haven CT, Trumbull CT, Newton MA, Boston MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07090499
Phase1, Recruiting
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New Haven CT, Hackensack NJ, Toronto, Halifax,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06988488
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluation of a Mobile App Program for Coping With Cancer
for
Cancer
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT06923501
Recruiting
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
for
Myelodysplastic Syndromes
Location: New Haven CT, Toronto, Calgary, Canton OH, Houston TX,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06847867
Phase2, Recruiting
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
for
Locally Advanced/Metastatic Solid Tumors
Location: New Haven CT, Indianapolis IN, Nashville TN, Denver CO,
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All
Age: 18+
Code: NCT06414460
Phase1, Phase2, Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: New Haven CT, Lake Success NY, Boston MA, New York NY,
Sponsor: AVEO Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06064877
Phase3, Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children
for
Invasive Candidiasis
Location: New Haven CT, Boston MA, New York NY, Philadelphia PA,
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0+
Code: NCT05763251
Recruiting
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
for
Endometrial Cancer
Location: New Haven CT
Sponsor: Alessandro Santin
Sex: Female
Age: 18 - 70+
Code: NCT03832361
Phase2, Recruiting
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
for
Ovarian Cancer Recurrent
Location: New Haven CT, Boston MA, New York NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT06843447
Phase1, Phase2, Recruiting
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
for
Breast Cancer, Hyperinsulinism, HER2-negative Breast Cancer
Location: New Haven CT
Sponsor: Yale University
Sex: Female
Age: 18+
Code: NCT05989347
Phase1, Recruiting
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
for
Advanced Breast Cancer
Location: New Haven CT, Mineola NY, Boston MA, New York NY,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06638307
Phase1, Recruiting
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for
AML, AML With Mutated NPM1, Hematologic Malignancy, KMT2Ar,
Location: New Haven CT, Stony Brook NY, Lake Success NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06001788
Phase1, Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: New Haven CT, Boston MA, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors